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Abstract
Background: The phase of a circadian rhythm reflects where the peak and the trough occur, for
example, the peak and trough of performance within the 24 h. Light exposure can shift this phase.
More extensive knowledge of the human circadian phase response to light is needed to guide light
treatment for shiftworkers, air travelers, and people with circadian rhythm phase disorders. This
study tested the hypotheses that older adults have absent or weaker phase-shift responses to light
(3000 lux), and that women's responses might differ from those of men.
Methods: After preliminary health screening and home actigraphic recording baselines, 50 young
adults (ages 18–31 years) and 56 older adults (ages 59–75 years) remained in light-controlled
laboratory surroundings for 4.7 to 5.6 days, while experiencing a 90-min ultra-short sleep-wake
cycle. Following at least 30 h in-lab baseline, over the next 51 h, participants were given 3
treatments with 3000 lux white light, each treatment for 3 h, centered at one of 8 clock times. The
circadian rhythms of urinary aMT6s (a melatonin metabolite), free cortisol, oral temperature, and
wrist activity were assessed at baseline and after treatment.
Results: Light (3000 lux for 3 h on 3 days) induced maximal phase shifts of about 3 h. Phase shifts
did not differ significantly in amplitude among older and young groups or among women and men.
At home and at baseline, compared to the young, the older adults were significantly phase-advanced
in sleep, cortisol, and aMT6s onset, but not advanced in aMT6s acrophase or the temperature
rhythm. The inflection from delays to advances was approximately 1.8 h earlier among older
compared to young participants in reference to their aMT6s rhythm peaks, and it was earlier in
clock time.
Conclusion: In these experimental conditions, 3000 lux light could shift the phase of circadian
rhythms to about the same extent among older and young adults, but the optimal light timing for
phase shifting differed. For an interval near 4 PM, bright light produced only negligible phase shifts
for either age group.
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The phase of a circadian rhythm reflects where the peak
and the trough occur, for example, the peak and trough of
performance within the 24 h. It may be desirable to shift
this phase, for example, to shift the time when peak per-
formance occurs. Normally, circadian rhythms are syn-
chronized with the 24.0 h environment by stimuli which
alter the phase of the underlying brain circadian pace-
maker. For most organisms, including mammals, the pri-
mary phase-shifting stimulus is light [1]. Effects of light in
shifting human circadian rhythms have been described
for several decades [2].
The relationship of the phase shifts in the organism to the
circadian timing of the stimulus is called the phase
response curve or PRC [3,4]. Several partial or complete
PRCs of the human response to light have been experi-
mentally determined [5-12].
More knowledge of human phase response curves to light
is needed, now that bright light is being used increasingly
to correct circadian rhythm phase disorders such as
delayed sleep phase syndrome, to help air travelers adapt
to jet lag, and to assist shift workers with adjustment to
difficult schedules. The phase-shifting effects of light may
also be relevant to treatment of depression [13-16]. The
limitations of currently-available human PRC data have
included a predominant focus on males (with very little
phase-response data on women available), a paucity of
comparative data by age groups contrasted simultane-
ously, and insufficient data points to accurately determine
the shape of the PRC over the entire circadian cycle with
stimuli of varying strength.
Different light stimuli patterns may produce PRCs of dif-
ferent shape and amplitude. Some previous PRC studies
have used 5–6 h durations of extremely bright light
(10,000 lux) which might be poorly tolerated or difficult
to apply in normal life. In this study, 3000 lux (in a hori-
zontal direction of gaze) was selected as approximately
the brightest stimulus which could be practically and
comfortably applied through overhead lighting in our iso-
lation rooms. A 3-h stimulus was chosen to fit within the
timing of our experimental model and be somewhat com-
parable to the exercise duration. The light stimuli were
given on 3 consecutive days to augment the effect, as other
studies have previously done [6]. Note that light stimuli
on 3 consecutive days may produce entrainment
responses qualitatively different from those of a single
stimulus, because the circadian system may shift its phase
during the interval while the light pulses are being given.
Because of concern that aging or gender might diminish
phase-shifting responses, this research was planned to
examine light PRCs simultaneously obtained from groups
of women and men of both older (ages 59–75) and
young-adult age groups (ages 18–31). The participants
were randomly assigned to either bright light or treadmill
exercise stimuli, so that light and exercise PRCs could be
contrasted. The exercise PRCs will be reported elsewhere.
This presentation will describe the light PRCs obtained
from two different age groups and both genders.
Methods
By advertising and word of mouth, the investigators
recruited 337 volunteers who signed initial consent for
the study. The study was approved and undergoes contin-
uing annual review by the UCSD Human Research Protec-
tions Program (IRB) and the affiliated IRB of the VA San
Diego Healthcare System. It was conducted in accord with
the principles expressed in the Declaration of Helsinki.
The target ages for young adults were 18–30 years and for
older adults were 60–75 years. We sought both older and
young-adult participants who were aerobically fit and in
good general health, so that they would be capable of
undergoing the exercise condition if randomized to that
treatment. An inclusion criterion was regular participation
in aerobic exercise for ≥20 min/day, ≥3 times/week at an
intensity of ≥60% of maximal effort. Many of the volun-
teers were quite successful competitive endurance athletes
(particularly those in the older group). All volunteers
underwent medical histories, physical examinations,
blood sugar, cholesterol and lipoprotein screening, and
physician-supervised monitored exercise to verify the
absence of EKG abnormalities. About 1/3 of the initial
volunteers were dropped during the screening process for
exercise safety considerations (e.g., high cholesterol or
EKG abnormalities during monitored exercise) or because
they decided they did not wish to complete the protocol.
Also, potential participants were excluded if they took
medications thought to influence melatonin or cortisol
(e.g., melatonin, beta blockers, high doses of aspirin, cor-
ticosteroids). More older than young participants were
recruited, because it was predicted a larger N might be
needed for adequate power to detect a PRC in the older
age group.
Preliminary screening studies included sleep and medical
history forms and the Pittsburgh Sleep Quality Index
(PSQI) [17]. Some of the PSQI results have been reported
elsewhere [18]. For 7 days before entering the laboratory,
participants wore the Actillume-I wrist actigraph for con-
tinuous 24-h recording of activity and illumination expo-
sure. Sleep-wake was inferred by validated algorithms
[19,20]. During the same week, participants completed
home sleep logs estimating sleep time and quality, and
completed a baseline Center for Epidemiologic Studies
Depression Scale (CESD) [21]. The CESD was repeated
both on the first and last days in the laboratory and one
week later, to measure any mood effects of the interven-Page 2 of 13
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caffeine for 2 days before entering the laboratory.
Participants first entered the Circadian Pacemaker Labora-
tory at about 09:30 and were assigned to individual studio
apartments with sound and light isolation. They were
asked to remain in their rooms or in a hallway with illu-
mination limited to 50 lux for the duration of their time
in the laboratory, from 4.7 to 5.6 days. They were not per-
mitted in distant parts of the laboratory near windows or
daylight. During their entire time in the laboratory, they
were instructed to follow a special ultra-short sleep-wake
cycle, consisting of 30 min in bed in complete darkness
with sleep encouraged, followed by 60 min out of bed in
background illumination, which was maintained at <50
lux in the usual direction of gaze. The ultra-short sleep
wake cycle is a protocol used successfully by several labo-
ratories to reduce sleep and light masking of circadian
rhythms [22-26]. Although maintained in standardized
lighting and ultra-short sleep-wake cycles, participants'
social interactions were not restricted. Visitors and con-
tacts with staff were permitted, along with reading, watch-
ing television (less than 10 lux), craft projects, working at
computer games (less than 8 lux), telephone calls, and
preparing meals. Strenuous exercise was not permitted.
Baseline observations were continued for the first 30–53
h, of which the final 24 h were analyzed for baseline cir-
cadian assessments. Almost all participants were rand-
omized to receive bright 3000 lux light stimuli or exercise
when they first entered the laboratory, without being
advised in advance of what treatment they would experi-
ence at what times of day. Because of difficulties recruiting
healthy participants, 7 older volunteers were invited to
enter the light protocol several months after having com-
pleted the exercise protocol to which they had initially
been randomized. After a baseline of varying length, par-
ticipants commenced bright light exposures centered at
one of 8 times: 0100, 0400, 0700, 1000, 1300, 1600,
1900, or 2200 h. The 8 protocols are illustrated in Fig. 1.
A 3-h block of bright light treatment was administered at
the same time of day for 3 days. The bedrooms of about
18 m2 were painted with white reflective paint. The ceil-
ings had 8 recessed fixtures, each with a diffuser covering
six 4-foot T12 cool white 4100, 40-watt fluorescent bulbs
(Philips F4C Advantage X). The lights were controlled
externally. For bright light treatments, all bulbs were lit,
whereas for 50 lux, only one dimmer bulb was used. The
ceiling fluorescent lighting provided approximately 3000
photopic lux to the cornea in a horizontal direction of
gaze (see Fig. 2). Structured block randomization was
employed so that approximately equal numbers were
assigned to each of the 8 bright light stimulus times.
The experimental protocolsFigure 1
The experimental protocols. The experimental proto-
cols are shown with an ordinate of 1 line per day and an 
abscissa of 24 h from midnight to midnight. Volunteers 
arrived in the laboratory at 09:30 on day 1. The ultra-short 
sleep-wake cycle, consisting of 30 min for sleep (black bars) 
followed by 60 min for wake (shaded bars) began at 10:30 
and continued for 4.7 to 5.6 days. Three consecutive treat-
ments (3 h bright light, yellow areas) were commenced after 
38–54 h of baseline at one of 8 times. Circadian phase was 
assessed during the final 24 h of baseline preceding the first 
experimental treatment and for 24 h starting 6 h after the 
last treatment.Page 3 of 13
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graphs throughout their time in the laboratory. Oral tem-
peratures were taken with fast-reacting high-resolution
electronic thermometers every 30 minutes. Because of
superior circadian goodness of fit, only those oral temper-
ature measurements obtained every 90 min immediately
after awakening were used to obtain circadian analyses.
Since these latter temperature measurements were each
made in bed after 30 min. lying in bed, temperature was
measured in a sort of constant routine which would min-
imize any effects of posture, activity, or meals. We did not
think that the advantages of rectal temperature recording
would outweigh the inconvenience and risks to partici-
pants. During the baseline and again after the final bright
3000 lux light stimulus, every urine voiding was collected.
With few exceptions, participants provided a urine speci-
men each 90 min during lights-on, drinking at least 200
cc every 90 min to maintain steady production. The vol-
ume of each urine sample was measured and aliquots (2
ml) were immediately frozen and then soon transferred to
-70°C, where the samples were stored for later assays of 6-
sulphatoxymelatonin (aMT6s) and urinary free cortisol.
Visual-analog 100 mm line ratings were given on 8 scales
every 3 h: these scales were ALERT, SAD, TENSE, EFFORT,
HAPPY, WEARY, CALM, SLEEPY, AND OVERALL. Monk
and colleagues have validated similar scales in time-isola-
tion laboratory settings [27]. The CESD inventory was
repeated near the beginning and towards the end of the
laboratory stay.
aMT6s
The aMT6s assays were performed using Bühlmann 96
well ELISA kits (EK-M6S) purchased from ALPCO, Ltd.
(Windham, NH). At the usual dilution of 1:200, the ana-
lytical sensitivity of the EIA was 0.35 ng/ml and the func-
tional least detectable dose was 1.3 ng/ml for coefficients
of variation (CVs) <20%. In our laboratory, control urine
samples averaging 4–6 ng/ml gave intra- and inter-assay
CVs of 4% and 7%, respectively. All samples from an indi-
vidual participant were run at the same time and wherever
possible on the same 96-well plate. Selected samples
(especially peak or "circadian night" samples measuring >
38 ng/ml or samples < 1 ng/ml) were assayed repeatedly
at either increased (1:800 to 1:3200) or decreased (1:25 to
1:100) dilution when necessary to obtain more accurate
estimates or to clarify irregular circadian patterns in excre-
tion rate (ng/hr).
From the aMT6s concentration, the urine volume, and the
collection times, the aMT6s excretion rate (ng/h) was
computed for each collection interval (the interval
between one voiding and the next one) and subsequently
associated with each 5-min interval within the collection
interval. From this time series of 5-min intervals, the cir-
cadian analyses were computed (see below).
Urinary free cortisol
Urine samples were assayed for free cortisol using DSL-
2100 Active Cortisol RIA kits (Diagnostic Systems Labora-
tories, Inc. Webster, Texas). Because our 90 min sampling
protocol typically yielded somewhat dilute urine, the
urine sample volume in the RIA was increased to 75 μl
combined with 25 μl of zero calibrator, adjusting the vol-
ume of kit standards and controls accordingly (e.g. 25 μl
standards plus 75 μl deionized water). A low dose control
(mean 1.3 μg/dL) run in triplicate in 12 assays gave intra-
and inter-assay coefficients of variation (CVs) of 6.8% and
8.7%, respectively. Samples measuring <0.16 or >20.0 μg/
dL when run at 75 μl were reassayed using either 250 μl or
25 μl of sample to obtain more accurate estimates. As with
aMT6s, the cortisol concentrations were used to infer cor-
tisol excretion for each 5 min interval. Because the urine
integrates the pulsatile secretion of cortisol into blood,
fewer urine samples than blood samples are needed to
obtain a precise assessment of the phase of the circadian
system. However, interim analyses suggested that urinary
cortisol was not yielding more reliable circadian informa-
tion than aMT6s, so cortisol was not assayed for the final
third of laboratory studies.
Circadian Analyses
Separate analyses were done for the last 24 h of baseline
90-min sleep-wake cycle, before light treatment, and for
the comparable final 24 h of follow-up laboratory 90-min
cycle (starting 6 h after the end of light treatment to min-
imize transients). For measures such as urinary aMT6s,
urinary cortisol, oral temperature, and actigraphic
minute-by-minute scored sleep, the best-fitting 24-h
The light spectrum of the bright light treatmentFigure 2
The light spectrum of the bright light treatment. The 
spectral content of the bright light treatment measured at 
eye level (standing) was averaged for the 3 subject rooms. 
The abscissa is wavelength in nanometers.Page 4 of 13
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the acrophases (peak of the fitted curve) and mesors
(mean of the fitted curve) were obtained as the estimates
of the daily mean excretion and circadian timing. Baseline
results from some of the first participants in this study,
combined with some of the participants who would be
assigned to exercise, have been reported previously
[18,28]. Each phase response resulting from bright light
stimuli was then computed, e.g., as the acrophase of the
baseline minus the acrophase of the follow-up interval. A
negative phase shift indicated a delay, e.g., that the acro-
phase of the rhythm occurred at a later clock time after the
stimulus than during baseline. A positive phase shift
would indicate an advance, e.g., that the acrophase was at
an earlier time at follow-up than at baseline. The phase
shifts from baseline to follow-up were then related to the
time lag between the center time of the 3-h light stimulus
and the baseline acrophase of aMT6s (or temperature, cor-
tisol, etc.) to form the phase-response curves for each var-
iable studied with each phase reference.
At the same time that these experiments were performed,
a separate group of men and women of similar ages were
exposed to the 90-min ultra-short sleep-wake cycle in the
same laboratory with no more than 50 lux light exposures
[29]. These subjects appeared to free-run with a period
averaging 24.38 h [29]. Thus, for the participants exposed
to bright light, the phase shifts were interpreted as relative
advances or delays in reference to their mean phase shift,
which approximated the free-running delay among the
untreated subjects. The mean of the participants undergo-
ing bright light stimuli was regarded as the best estimate
for their free-running trend, because the untreated sub-
jects were selected by different criteria and were in the lab-
oratory for a shorter duration, so their estimated free-
running period might have been more affected by tran-
sients.
To further describe changes in circadian phase and wave-
form, we estimated the circadian timing of nocturnal
aMT6s onsets and offsets algebraically from upward
(onset) and downward (offset) crossings of the mesor
(ng/h), calculated from 24 h cosine fits to the data (Fig. 3).
Shifts in onset and offset times were also computed. To
aide interpretation of the PRC data in relation to clock
timing in the home environment, some of the figures
plotted phase shifts to light on a 24 h abscissa titled Cir-
cadian Clock Time (Figures 4, 5, 6). The abscissa Circa-
dian Clock Time references the timing of light stimulation
to a phase marker (i.e., aMT6s acrophase or onset), and
then displays the environmental time scale corresponding
to when the mean phase marker occurred at baseline. The
mean phase markers used are also located on the time
scale as asterisks. This form of display illustrates our best
estimate of the mean environmental clock time at which
the stimuli were given, adjusted for variations in each par-
ticipant's baseline phase.
To test the null hypothesis that there were no phase-
response curves, that is, no phase-shifts dependent on the
timing of the 3000 lux light stimuli, we used both the PRC
bisection test [30] and factorial ANOVA. The PRC bisec-
tion test locates the best bisection of the circular distribu-
tion of initial phases to maximize the contrast between
advances and delays. In general, the best bisection will be
at the inflection from delays to advances. The test then
determines if the bisection separates advances and delays
significantly better than would occur in a random distri-
bution. These tests were performed for all 106 participants
and on subgroups of older and young adults, male and
female. The inflection points of the PRCs from delay to
advance were estimated with the PRC bisection analyses.
The amplitudes of PRCs were contrasted between older
and young adult groups, men and women, using methods
derived from the PRC bisections [30]. Because the PRC
bisection test was a new approach, these tests were con-
firmed by factorial ANOVA, allocating the phase shifts
into 6 prospectively-planned 4 h treatment-timing blocks
(referenced to the baseline acrophases), and adding age
group and gender as additional factors to produce 6 × 2 ×
2 analyses. A criterion for significance of p < 0.05 was
selected. No correction for multiple testing seemed appro-
priate, since most tests were significant, and correction
would be problematic with tests which were intercorre-
lated.
Results
A total of 50 young adults ages 18–31 years (mean 23)
and 56 older adults ages 59–75 years (mean 67) com-
pleted the protocol and supplied usable data. The young
adults included 31 women and 19 men. The older adults
included 28 women and 28 men. Seven additional partic-
ipants entered the laboratory, but dropped out in the first
2 days before receiving randomized treatment, mostly
with headache complaints. These complaints decreased
after a room ventilation problem was identified and
resolved. One participant quit during bright light treat-
ment because a personal responsibility arose unexpect-
edly. The studies were done from September, 1999
through March, 2003, both age groups and both genders
being studied simultaneously at all times of year.
Some characteristics of the participants at baseline are
shown in Table 1.
The bright-light phase response curves for young and
older adults are shown in Fig. 4, using the aMT6s acro-
phases as the reference. The participants showed a trend to
delay an average of 1.09 h between the phase assessments,
which were centered 81 h apart. This would correspond toPage 5 of 13
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ference between the average delay of older and young
adults, 0.93 and 1.27 h respectively. Light stimuli centered
from 8 h before the aMT6s acrophase roughly up to the
acrophase produced phase delays as referenced to this
mean shift. Light stimuli in approximately the first 10 hs
after the aMT6s acrophase produced phase advances as
referenced to the mean shift. For the older participants,
the inflection of the trend line from delays to advances
crossed the mean phase response line about 0.2 h before
the aMT6s acrophase, whereas among the young, this
inflection crossed the mean phase response line at 1.6 h
after the aMT6s acrophase, a difference of 1.8 h. Fig. 4B
emphasizes that the PRC inflection times of the older sub-
jects were more than 1.8 h earlier than those of the young
in reference to clock time. From about 10 to 16 h after the
Profiles of aMT6s excretionFigure 3
Profiles of aMT6s excretion. Examples of urinary aMT6s interpretation are plotted for one male participant, age 61 years 
(A and C), and one female participant, age 28 years (B and D). Panels A and B plot aMT6s (ng/h) in blue longitudinally during 
the two segments of continuous collection used for baseline and post-treatment phase assessment. The abscissa is h from the 
midnight commencing the first laboratory day (broken axis to omit 2 days of treatment). A cosine curve was fit to the 24 h 
immediately prior to the first light pulse (white bar) and again to the last 24 h. The horizontal red dotted lines represent the 
mesors (fitted means) associated with each cosine. Filled circles show the time of the cosine acrophases before (black), and 
after (grey) light treatment. Times of aMT6s onsets and offsets are represented respectively by upward and downward pointing 
arrows (black arrows for baseline and grey arrows for post-treatment.) The light-induced phase shifts in circadian aMT6s pro-
files are illustrated in panels C and D by replotting both baseline (1, black line) and post-stimulus curves (2, red line) on a 
noon-to-noon abscissa. In A and C, light given 8–11 PM, elicited phase delays of -5.0, -3.3, and -5.9 h, respectively, in the 
aMT6s acrophase, onset and offset. In B and D, the light stimulus given 5–8 AM produced phase advances of 1.2, 1.1, and 1.1 h, 
respectively. Note that the phase shifts were well-demonstrated despite the lower aMT6s excretion in the older participant.Page 6 of 13
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mean shift, averaging -1.06 h; that is, from 10 to 16 h after
the aMT6s acrophase, there appeared to be a dead-zone
Phase shifts of acrophase of aMT6s rhythmFigure 4
Phase shifts of acrophase of aMT6s rhythm. A. Phase 
shifts in the aMT6s circadian rhythm resulting from light stim-
uli are shown for 106 participants. The ordinate shows the 
shift in h of the aMT6s acrophase, computed as the baseline 
aMT6s acrophase minus the acrophase after the 3 bright light 
treatments. Thus negative shifts indicate that the follow-up 
acrophase was later than the baseline acrophase, i.e., delayed 
in clock time. The abscissa represents the timing of the mid-
points of the 3-h light stimuli, as referenced to the baseline 
aMT6s acrophase. Stimuli given with an abscissa near 0 were 
approximately centered at the baseline aMT6s acrophase. 
Black circles represent phase shifts of individual young adult 
participants, and red triangles represent phase shifts of older 
participants. The solid black horizontal line shows the mean 
of all points, approximating the phase shift resulting from the 
circadian free-running component. The black dashed and red 
lines represent the trends from 5-point moving averages for 
the young and older groups. Rectangles illustrate the average 
actigraphic home sleep times for the young and older groups, 
referenced to their aMT6s acrophases. B. The phase shifts in 
aMT6s acrophase were averaged to show the mean ± 1 SEM 
for 2-h bins of time-of-stimulation referenced to the aMT6s 
acrophase. "The abscissa (Circadian Clock Time) references 
the midpoint of 3 h light stimuli to the time of the baseline 
aMT6s acrophase, and then displays the environmental time 
scale corresponding to when the mean aMT6s acrophase 
occurred at baseline. Thus the Circadian Clock Time abscissa 
(Figs 4-6) also represents our best estimate of the mean envi-
ronmental clock time at which bright light stimuli occurred, 
adjusted for each participant's baseline circadian phase 
(aMT6s acrophase or onset). The asterisks illustrate the 
mean aMT6s acrophase times for the young and older 
groups.
Phase shifts of onsets of aMT6s rhythmFigure 5
Phase shifts of onsets of aMT6s rhythm. A. Time shifts 
in aMT6s onsets are contrasted in young and older groups. 
The abscissa represents the time of bright light stimuli (mid-
point of 3 h pulse) in reference to the time of the aMT6s 
onset at baseline. Trend lines for each age group represent 5-
point moving averages. Relative to baseline aMT6s onsets, 
the inflection from delays to advances occurred earlier in the 
older adults. B. The shifts in aMT6s onsets were averaged to 
show the mean ± 1 SEM shift in onset times for non-overlap-
ping bins of time-of-stimulation referenced to aMT6s onset. 
The abscissa (Circadian Clock Time) is our best estimate of 
the mean clock time at which bright light stimuli occurred, 
adjusted for each participant's aMT6s onset time. Asterisks 
represent the mean onsets for young and older groups.Page 7 of 13
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phase responses was observed.
Outcomes of the PRC bisection tests are summarized in
Table 2, which gives the estimated angle of the inflection
from the phase reference, the mean clock time to which
that estimated inflection would correspond, the D param-
eter which reflected the amplitude of the PRC, the number
of subjects, and the probability of the null hypothesis.
Referencing phase responses in the aMT6s acrophases to
the baseline aMT6s acrophases, the overall PRC bisection
test for all participants gave a highly significant rejection
of the null hypothesis of no PRC. This was also the case for
subgroups of all older, all young, all males, and all
females. The PRCs of each of these four subgroups were
highly significant, had a similar D score estimating the
amplitude of the PRC, and similar estimated phases of the
inflection point from delays to advances (adjusted for
mean shifts). The results for the much smaller age-gender
subgroups shown in Table 2 were also rather similar,
though the bisection test for older males missed the 0.05
significance criterion. Using factorial ANOVA to contrast
PRC amplitudes derived from the PRC bisection proce-
dure (see [30]), no significant differences in PRC ampli-
tude were found between older and young groups or
between female and male groups, nor was the age X gen-
der interaction significant. It appeared that the largest dif-
ference in inflection phases was between older and young
females, but the 95% confidence limits for inflection
phases derived from the PRC bisection test overlapped
when comparing the older and young female subgroups.
Whether the treatment time was referenced to the baseline
aMT6s acrophase or to the baseline cortisol acrophase,
cortisol phase responses were similar to those for aMT6s,
but the bisection tests for cortisol were not significant for
the younger group with N = 42. The D scores for oral tem-
perature phase responses were rather high, but the bisec-
tion tests were not significant for the older participants,
whether treatment timing was referenced to oral tempera-
ture baseline phases or to aMT6s baseline phases. Bisec-
tion results for actigraphic sleep phase responses
resembled those of the other variables, but the tests were
not as highly significant, in as much as the circadian
amplitude/mesor ratios of actigraphic sleep rhythms were
not as high as for the urine variables or oral temperature,
and the circadian phase estimates were accordingly less
precise.
Factorial ANOVA of aMT6s acrophase responses for all
participants demonstrated a highly significant time-of-
treatment effect (F5,82 = 15.98, P < 0.0001), confirming a
significant PRC. There were no significant main effects of
age group or gender and no interactions of age or gender
with the time-of-treatment. However, when examining
the phase shifts for the onset of aMT6s, referencing light
treatment time to aMT6s onset, the interaction effect of
age and time of treatment was almost significant (P =
0.054), reflecting the earlier inflection among older par-
ticipants. A similar ANOVA for cortisol phase response
showed no significant time-of-treatment effect, whether
the time of treatment was referenced to baseline aMT6s or
to cortisol acrophases. The time-of-treatment effect in
ANOVA for temperature responses referenced to aMT6s
was significant at the P = 0.01 level with no significant age
or gender effects or interactions. Referenced to baseline
temperature acrophases, this temperature ANOVA was
slightly less significant, P = 0.023. In the sleep phase
responses ANOVA, the time-of-treatment effect was barely
Phase shifts of onsets, offsets, and duration of aMT6s rhythmFigure 6
Phase shifts of onsets, offsets, and duration of aMT6s 
rhythm. A. The time shifts for aMT6s onsets (black trian-
gles) and offsets (red triangles) are contrasted, after averag-
ing the data in 2 h bins showing the mean ± 1 SEM shifts in 
time, referencing time-of-stimulation to aMT6s onset. The 
abscissa (Circadian Clock Time) represents our best esti-
mate of the mean clock time at which bright light stimuli 
occurred, adjusted for each participant's aMT6s onset time, 
as in Figure 5. The asterisks show mean aMT6s onset and off-
set times for all 106 participants. B. The change in mean 
aMT6s duration resulting from unequal shifts in aMT6s onset 
and offset is plotted, using the same bins and abscissa as 
above.Page 8 of 13
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interaction was significant with P = 0.007, and an age X
gender interaction was significant with P = 0.005, without
any interaction of age with time of treatment.
There was no time-of-treatment effect on the final aMT6s
mesors or circadian amplitudes determined by cosine fits.
Phase shifts in aMT6s onsets and offsets were generally
similar to those of the acrophases. However, because the
aMT6s onsets were more advanced in the older compared
to younger participants than were the baseline acro-
phases, the entire PRC waveform for shifts in the older
group was more clearly phase advanced when referenced
to onsets in circadian-adjusted time (Fig. 5B). Moreover,
because the aMT6s onsets delayed more than the offsets in
the phase-delay regions of the PRCs, the post-treatment
Table 2: PRC Bisection Test Inflection Phases and Clock Times of Inflection
GROUP INFLECTION referenced to acrophase TIME (mean) D N P
aMT6s phase shifts referenced to aMT6s acrophase
All ages 21.3° 4:56 36.9 106 <0.0001
Young males 21.3° 5:29 37.4 19 0.004
Young females 45.3° 6:37 38.7 31 0.007
Older males 29.1° 5:23 28.8 28 0.087
Older females 1.6° 3:49 45.35 28 <0.0001
cortisol phase shifts referenced to baseline aMT6s acrophase
All ages 4.5° 3:49 35.6 73 0.0005
oral temperature phase shifts referenced to baseline oral temperature acrophase
All ages 159.6° 3:31 55.0 96 <0.0001
lab actigraphic sleep phase shifts referenced to baseline aMT6s acrophase
All ages 10.7° 4:14 38.0 102 0.03
Shifts in aMT6s onset, offset, and duration, with treatment time referenced to aMT6s acrophase
aMT6s onset 27.5° 05:21 33.9 104 <0.0001
aMT6s offset 14.1° 04:28 22.5 104 <0.02
aMT6s duration* 29.1° 05:28 1.06 h 104 P < 0.01
* The bisection test was modified to determine if changes in aMT6s duration were random in phase
Table 1: Baseline Characteristics of Participants (Mean ± SD)
YOUNG ADULT OLDER AGE CONTRAST
Wake-up (questionnaire) 7:31 ± 1:24 5:55 ± 1:18 P < 0.001
Actigraphic wake time 8:32 ± 2:16 6:39 ± 1:07 P < 0.001
Bedtime (questionnaire) 23:48 ± 1:03 22:51 ± 1:05 P < 0.001
Bedtime (actigraph) 00:33 ± 1:31 22:41 ± 1:24 P < 0.001
Sleep log total sleep time 444 ± 65 min 406 ± 63 min P = 0.003
Actigraphic total sleep time 404 ± 70 min 385 ± 68 min NS
aMT6s onset 23:04 ± 1:45 22:16 ± 1:46 P = 0.02
aMT6s acrophase 3:47 ± 1:37 3:18 ± 1:58 NS
aMT6s offset 08:22 ± 1:28 08:20 ± 2:11 NS
Cortisol acrophase 9:59 ± 1:54 8:29 ± 2:51 P = 0.008
Oral Temperature 
bathyphase
04:04 ± 2:10 04:44 ± 3:52 NS
PSQI total score 3.8 ± 2.3 3.6 ± 2.7 NS
CESD at intake 7.0 ± 7.0 3.5 ± 3.6 P = 0.002
NS = Not Significant. Temperature bathyphase: the fitted minimum, 180° from the acrophase.Page 9 of 13
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time-of-treatment by the bisection test (P < 0.01), as
shown in Table 2 and Fig. 6B. This effect on duration was
confirmed by ANOVA (P < 0.05). Fig. 6B indicates that
light stimuli given near 4 PM or near 8 AM induced a
lengthening of the aMT6s duration.
In 41 pairings where PRC bisection tests and time-of-treat-
ment ANOVA were both computed, the PRC bisection test
yielded more significant P values in 27 cases and ANOVA
in 14. The correlation of log-transformed P values for the
two methods was r = 0.83.
The mean CESD score increased from 4.9 at home base-
line to 6.5 on the first day in the laboratory, 7.6 on the last
day in the laboratory, and 6.1 on one-week follow-up (p
< 0.03, one-way ANOVA), indicating slight increases in
depression from baseline. The CESD scores following
bright light treatment were not influenced by the timing
of the treatment. Examining visual-analog scores at the
end of treatment (Day 5 average) with repeated measures
ANCOVA, the time of day of treatment referenced to
aMT6s acrophase produced no significant effects on
mood. However, as the study terminated, compared to the
young adults, the older participants rated themselves as
significantly more alert, calm, happy, and better in the
overall score, but less sleepy, tense, weary, and sad.
No serious or lasting adverse effects of these experiments
were observed.
Discussion
These results again demonstrate the circadian phase-shift-
ing effects of bright 3000 lux light and describe phase
response curves. These observations confirm previous
results that the inflection time from delays to advances
averages an h or two after midsleep, which tends to occur
earlier in older adults. The inflection time in aMT6s phase
shifts averaged slightly after the aMT6s acrophase. The
phase shift inflections were within the confidence limits
of the oral temperature bathyphases, which are the fitted
temperature minima, 180 degrees after the acrophases.
This would be consistent with the previous literature,
which located the inflection at approximately the core
temperature minimum. The study was prospectively
designed to have adequate power to detect PRC's in
groups of 48 participants or more. The highly significant
results for the aMT6s PRCs for older and young, men and
women, indicated that the study was adequately powered
for this purpose.
An important finding was that the light phase response
(PRC amplitude) in older participants was of similar size
to that of young adults. No predicted reduction in phase
response to light stimuli was observed among older par-
ticipants. Sufficient data had not been available to pro-
spectively predict the power of the model to contrast older
and young adults, as power predictions for PRC ampli-
tude are complicated by age differences in timing and
wave form. In retrospect, the data indicated that the exper-
iment had 80% power to detect if the PRC for one age had
twice the amplitude as that for the other age group (with
0.05 significance, two-tailed). Thus, a small difference in
the phase responsiveness between older and young partic-
ipants could not be excluded. Similarities in delay
responses to light between young and elder participants
were previously reported by others [11,31]. In one of 4
statistical tests, a greater advance response was observed
among young participants (P < 0.05 uncorrected for mul-
tiple comparisons), but interpretation was complicated by
lack of gender-matching of the groups and a shift in the
schedule for darkness and sleep [30]. One study suggested
that older adults were equally responsive to light stimuli
of the intensity we used, but older adults were less respon-
sive to dimmer light stimuli [32]. Because that was a ret-
rospective finding based mainly on 3 subjects, and the
groups were not studied simultaneously, more study of
responsiveness of aging adults to moderate light stimuli is
needed. Since we have found that subjects exposed to
more light at home are more advanced, decreased light
responsiveness would not explain why older adults are
more advanced [33]. It should be recognized that these
older participants with a mean age of 67 were very healthy
and aerobically fit. Their average aerobic capacity was in
the top 10% for their age. Selection might have biased
against older adults with visual handicaps, although par-
ticipants did not undergo specific ophthalmologic screen-
ing. It remains plausible that an even older age group with
substantial cataract or glaucoma might experience
decreased light responses, partly because their handicaps
might promote bright light avoidance [34]. One might
not expect macular degeneration to have much effect on
the retinal photic receptors which supply the retino-
hypothalamic tract [35], but associated photophobia
might limit daylight exposures.
These data allowed a contrast of light phase responsive-
ness between females and males of diverse ages. No signif-
icant difference between the phase responses of females
and males was observed, though the statistical power was
insufficient to detect small gender differences. Although D
scores in Table 2 suggested that older females tended to be
somewhat more light-responsive than older males, the
difference was in the consistency of the PRC responses
rather than in their range. It seems unlikely that light
phase responsiveness accounts for differences in home cir-
cadian phase adjustments between females and males.
An unusual feature of our study was the computation of
PRCs in multiple dependent variables, using acrophasesPage 10 of 13
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treatments. As we had anticipated, aMT6s provided the
most reliable marker that produced the most consistent
responses, as judged by the PRC amplitudes and statistical
significance. The PRCs using oral temperature, urinary
free cortisol, and actigraphic sleep as phase markers for
the time of light stimulation were consistent with the
PRCs using aMT6s for reference. Likewise, the PRCs for
temperature, cortisol, and sleep had similar D scores sum-
marizing PRC amplitudes and similar estimated inflec-
tions. The temperature, cortisol and sleep PRCs for some
subgroups were less statistically significant, probably
because of less reliable physiologic measurement, less
sinusoidal circadian waveforms, and in some cases, less
usable data available. For this reason, this presentation
focuses on aMT6s data. Parenthetically, this was our first
extensive utilization of the PRC bisection test, which was
designed for this study. Although statistical significance as
assessed by ANOVAs was well correlated with significance
estimated by PRC bisection tests, in almost 2/3 of compar-
isons, the PRC bisection test result proved more signifi-
cant, and the bisection test result was more often
significant than ANOVA.
From a theoretical viewpoint, since melatonin causes
much of the circadian variation in core body temperature
[36] and is masked little by sleep, melatonin is a logical
choice of circadian marker. Since the PRC's for the urinary
metabolite of blood melatonin, aMT6s, were more con-
sistently statistically significant than PRC's for oral tem-
peratures or other circadian markers, but not of higher
amplitude, it appeared that the acrophases of aMT6s had
less measurement error. We found actigraphic sleep very
difficult to score in the ultra-short sleep-wake cycle model,
and apart from scoring problems, we would expect sleep-
wake to be less tightly synchronized to the suprachias-
matic nucleus circadian pacemaker than melatonin or cor-
tisol. To the extent that the sleep-wake circadian rhythms
were of marginal amplitude, the 90-min sleep-wake cycle
presumably reduced sleep masking of other variables.
Cortisol and melatonin might be expected to be tightly
locked in phase, since both circadian rhythms are control-
led by suprachiasmatic nucleus efferents to the hypotha-
lamic paraventricular nucleus, but for demonstrating a
PRC, aMT6s appeared the more convenient and informa-
tive marker.
In these subjects, we found that sleep-wake at home and
cortisol circadian rhythms in the lab baseline were signif-
icantly advanced among the older adults (ages 59–75) as
compared to the young (ages 18–31), as was the aMT6s
onset. In some of the same subjects, Yoon et al. found that
the onset of melatonin excretion tended to be advanced
along with sleep and cortisol, but the offset of melatonin
was less advanced, resulting in a longer duration of esti-
mated melatonin excretion among the older participants
[28], as was likewise indicated in Table 2. This was largely
consistent with findings of other groups [37-39]. Similar
contrasts of young and older adults were also found in less
healthy elders using the same 90-min-day protocol [29].
In the latter study, slowed metabolism of melatonin
among older participants seemingly could be excluded,
suggesting that it was the actual offset of synthesis of
melatonin in the pineal, controlled by the suprachias-
matic nucleus circadian system, which became relatively
delayed in reference to the sleep and cortisol rhythms.
That body temperature was not found to be significantly
advanced among older participants may be partly attribut-
able to the regulation of body temperature by melatonin
and partly a reflection of less accurate circadian tempera-
ture measurement. This might raise the question whether
sleep-wake and cortisol assume a more advanced phase-
angle versus the suprachiasmatic circadian pacemaker as
we age, or whether body temperature and melatonin
secretion become more delayed, at least in the melatonin
synthesis offset.
Fig. 4 suggests that the PRC inflection from delay to
advance occurred earlier in reference to the aMT6s acro-
phase among the older adults. It was also earlier in refer-
ence to clock time. Assuming that the PRC inflection is a
good marker of the phase timing of the suprachiasmatic
nucleus circadian oscillator, Fig. 4 implies that among
older adults, the phase state of the suprachiasmatic
nucleus circadian oscillator does become advanced, but
the acrophase of the melatonin rhythm becomes relatively
delayed in reference to that suprachiasmatic nucleus oscil-
lator because the melatonin offset becomes delayed and
melatonin duration grows longer. Perhaps because core
temperature is governed in part by melatonin, it was not
surprising that the temperature acrophase was also
delayed in reference to the PRC inflection among the
older participants. Although the graphs appeared to dem-
onstrate a persuasive age difference in the inflection
points, since the statistical evidence was marginal that the
PRC inflection was earlier in reference to aMT6s acro-
phase among older participants, more study of this issue
is needed. A possible explanation might be that when
older adults arise early, sometimes before dawn, early
morning illumination bright enough to advance or
acutely suppress secretion of melatonin might not be
experienced correspondingly early [29]. By this mecha-
nism, aging-associated phase advances might influence
the entrainment of the complex circadian oscillator in a
manner somewhat analogous to the long nights of winter
[40], which prolong the duration of the circadian subjec-
tive night. It is entrainment state which is at issue, since
masking by light or sleep was equivalent among older and
young adults during the laboratory baseline urine collec-
tions.Page 11 of 13
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experienced for several weeks or more, has been suspected
as a cause of depression [14,41]; however, no correlation
was found among current participants between CESD in
the laboratory and any lag of aMT6s offset after average
home actigraphic wake time. A prolonged melatonin
duration (prolonged subjective night) might tend to
increase the phase responsiveness to light of elders, which
could possibly compensate for reduced ophthalmic light
transmission [42-44]. Fig. 6B shows that the specific tim-
ing of light stimuli varied the duration of melatonin secre-
tion acutely, but further study is needed to learn whether
this would occur with chronic treatment of a subject syn-
chronized in the home environment.
In this experimental model, we observed a dead zone of
approximately 6 h duration surrounding the core temper-
ature acrophase, when little if any circadian phase shift as
referenced to the mean shift was produced by 3000 lux
light stimuli. This was in contrast to a previous report
which observed no dead zone [45]; however, the trials in
that study involved strong and complex stimuli, including
shifting the times of 8-h intervals of bed rest in darkness.
More moderate bright light stimuli produced human
PRCs with a dead zone [8,46]. A relationship of PRC stim-
ulus strength to the presence or length of a dead zone has
been observed in laboratory animals. The existence of a
dead zone in human PRCs is an important observation,
indicating that most light exposures of the strength we
employed would have minimal phase-shifting effects dur-
ing much of the daytime h (e.g., from approximately 1:40
PM until 7:40 PM for a person awakening around 7 AM.)
The amplitude of the aMT6s PRC (Fig. 4, 5) was approxi-
mately 6 h, ranging from the maximal delay to the maxi-
mal advance in the averaged curves. If we assume that the
mean acrophase shift of 1.09 h was attributable to a free-
running component, 3 h was the maximal delay or
advance phase shift produced by 3 h of 3000 lux light
administered 24 h apart on 3 successive days. This was
roughly consistent with previous studies [8,32,46]. Our
PRC data as well as most other reports indicate that it
would be quite difficult to quickly achieve the 8–12 h
phase shifts desired by some air travelers and shiftwork-
ers. Complex aspects of experimental design can influence
the magnitude of resultant phase shifts and the shape of
PRCs. Factors influencing PRCs include stimulus parame-
ters such as the brightness and color spectrum of the stim-
ulus, the duration of daily exposure, the number of
repetitions (days) of stimulation, and the light levels
experienced at other times of day as well as management
of sleep, diet, posture, and social interactions. Because of
photostasis, retinal adaptation to light may alter
responses [47], so other factors might include illumina-
tion levels experienced before entry into the experiment,
the duration and the intensity of baseline illumination.
The duration of the prior photoperiod also may influence
the shape and amplitude of the PRC [42-44]. Much more
data are needed to clarify these many issues and to opti-
mize phase responses.
Conclusion
These experiments showed relatively similar amplitudes
of phase response to 3000 lux light among older and
young adults, and among women and men. The timing of
the advance and delay regions of the older and young
adults is clarified, under stimulation with moderately
bright light. Among older adults, the PRC and its inflec-
tion time was substantially advanced in reference to clock
time. Additionally, there was suggestive evidence for sub-
tle rearrangement of the phase relationships between var-
ious phase markers among older adults, the implications
of which deserve further exploration.
Competing interests
The author(s) declare that they have no competing inter-
ests.
Authors' contributions
DFK planned the study, was Principal Investigator of
HL61280, supervised the staff, assured participant safety,
contributed to statistical analyses, and wrote the first draft
of the manuscript. JAE planned the study, performed the
assays and endocrine analyses, prepared most of the fig-
ures, and contributed to writing. SDY planned the study,
recruited and screened participants, supervised techni-
cians and the day by day data collection, assembled the
data base, and contributed to data analyses and writing.
KMR took part in grant and study planning, handled
administrative and budgetary aspects of the study, main-
tained human subjects protection files, supervised techni-
cians, took part in data collection, and contributed to
writing. All authors read and approved the final manu-
script.
Acknowledgements
Anthony Cress, Patrick O'Brien, Gerard Huegel, Christopher Palmer, Jan-
ice Rosales, Abigail Gross, and Glinda Del Prado, M.D. gave great assistance 
in performing this study. Richard L. Hauger, M.D. supervised and main-
tained the laboratory where assays were performed. Funding was primarily 
provided by NHLBI HL61280, with further funding from HL07156001, 
HL071123 and NIMH MH68545. The Sam and Rose Stein Institute for 
Research on Aging, UCSD and the Veterans Administration Health System, 
San Diego provided facilities for this research.
References
1. Johnson CH, Elliott JA, Foster R, Honma K, Kronauer R: Fundamen-
tal properties of circadian rhythms.  In Chronobiology:  Biological
Timekeeping Edited by: Dunlap JD, Loros JJ and DeCoursey PJ. Sunder-
land, MA, Sinauer Associates, Inc.; 2004:67-105. 
2. Wever RA: Light effects on human circadian rhythms: A
review of recent Andechs experiments.  J Biol Rhythms 1989,
4(2):161-85.Page 12 of 13
(page number not for citation purposes)
Journal of Circadian Rhythms 2007, 5:4 http://www.jcircadianrhythms.com/content/5/1/4Publish with BioMed Central   and  every 
scientist can read your work free of charge
"BioMed Central will be the most significant development for 
disseminating the results of biomedical research in our lifetime."
Sir Paul Nurse, Cancer Research UK
Your research papers will be:
available free of charge to the entire biomedical community
peer reviewed and published immediately upon acceptance
cited in PubMed and archived on PubMed Central 
yours — you keep the copyright
Submit your manuscript here:
http://www.biomedcentral.com/info/publishing_adv.asp
BioMedcentral
3. Johnson CH: An Atlas of Phase Response Curves for Circadian and Circati-
dal Rhythms Nashville, TN, Vanderbilt University; 1990. 
4. Johnson CH: Forty years of PRCs - What have we learned?
Chronobiol Int 1999, 16(6):711-43.
5. Honma K, Honma S: A human phase response curve for bright
light pulses.  Jpn J Psychiat Neurol 1988, 42:167-168.
6. Czeisler CA, Kronauer RE, Allan JS, Duffy JF, Jewett ME, Brown EN,
Ronda JM: Bright light induction of strong (type 0) resetting of
the human circadian pacemaker.  Science 1989, 244:1328-1333.
7. Minors DS, Waterhouse JM, Wirz-Justice A: A human phase-
response curve to light.  Neurosci Lett 1991, 133:36-40.
8. Eastman CI: High-intensity light for circadian adaptation to a
12-h shift of the sleep schedule.  Am J Physiol 1992, 263(2 Pt
2):R428-R436.
9. Shanahan TL, Zeitzer JM, Czeisler CA: Resetting the melatonin
rhythm with light in humans.  J Biol Rhythms 1997, 12:556-67.
10. Khalsa SBS, Jewett ME, Duffy JF, Czeisler CA: The timing of the
human circadian clock is accurately represented by the core
body temperature rhythm following phase shifts to a three-
cycle light stimulus near the critical zone.  J Biol Rhythms 2000,
15:524-530.
11. Klerman EB, Duffy JF, Dijk DJ, Czeisler CA: Circadian phase reset-
ting in older people by ocular bright light exposure.  Journal of
Investigative Medicine 2001, 49:30-40.
12. Khalsa SBS, Jewett ME, Cajochen C, Czeisler CA: A phase-
response curve to single bright light pulses in human sub-
jects.  J Physiol (London) 2003, 549(Pt 3):945-952.
13. Lewy AJ, Bauer VK, Cutler NL, Sack RL, Ahmed S, Thomas K H.,
Blood ML, Jackson JML: Morning vs evening light treatment of
patients with winter depression.  Arch Gen Psychiatry 1998,
55:890-896.
14. Terman JS, Terman M, Lo ES, Cooper TB: Circadian time of morn-
ing light administration and therapeutic response in winter
depression.  Arch Gen Psychiatry 2001, 58:69-75.
15. Terman M, Terman JS: Light therapy for seasonal and nonsea-
sonal depression: efficacy, protocol, safety, and side effects.
CNS Spectr 2005, 10:647-663.
16. Lewy AJ, Lefler BJ, Emens JS, Bauer VK: The circadian basis of win-
ter depression.  Proc Natl Acad Sci U S A 2006, 103:7414-7419.
17. Buysse DJ, Reynolds CFIII, Monk TH, Berman SR, Kupfer DJ: The
Pittsburgh Sleep Quality Index: a new instrument for psychi-
atric practice and research.  Psychiatry Res 1989, 28(2):193-213.
18. Grandner MA, Kripke DF, Yoon IY, Youngstedt SD: Criterion valid-
ity of the Pittsburgh Sleep Quality Index:  Investigation in a
non-clinical sample.  Sleep and Biological Rhythms 2006, 4:129-136.
19. Jean-Louis G, Kripke DF, Cole RJ, Assmus JD, Langer RD: Sleep
detection with an accelerometer actigraph:  comparisons
with polysomnography.  Physiol Behav 2001, 72:21-28.
20. Jean-Louis G, Kripke DF, Mason WJ, Elliott JA, Youngstedt SD: Sleep
estimation from wrist movement quantified by different
actigraphic modalities.  J Neurosci Methods 2001, 105:185-191.
21. Radloff LS: The CES-D scale: A self-report depression scale for
research in the general population.  Applied Psychol Measurement
1977, 1:385-401.
22. Weitzman ED, Nogeire C, Perlow M, Fukushima D, Sassin J, McGre-
gor P, Gallagher TF, Hellman L: Effects of a prolonged 3-hour
sleep-wake cycle on sleep stages, plasma cortisol, growth
hormone, and body temperature.  J Clin Endocrinol Metab 1974,
38:1018-1030.
23. Carskadon MA, Dement WC: Sleep studies on a 90-minute day.
Electroencephalogr Clin Neurophysiol 1975, 39:145-155.
24. Lavie P: Ultrashort sleep-waking schedule. III. 'Gates' and 'for-
bidden zones' for sleep.  Electroencephalogr Clin Neurophysiol 1986,
63:414-25.
25. Buysse DJ, Monk TH, Carrier J, Begley A: Circadian patterns of
sleep, sleepiness, and performance in older and younger
adults.  Sleep 2005, 28:1365-1376.
26. Moul DE, Ombao H, Monk TH, Chen Q, Buysse DJ: Masking effects
of posture and sleep onset on core body temperature have
distinct circadian rhythms: results from a 90-min/day proto-
col.  J Biol Rhythms 2002, 17:447-462.
27. Monk TH: A visual analogue scale technique to measure glo-
bal vigor and affect.  Psychiatry Res 1989, 27:89-99.
28. Yoon IY, Kripke DF, Elliott JA, Youngstedt SD, Rex KM, Hauger RL:
Age-related changes of circadian rhythms and sleep-wake
cycles.  J Amer Geriat Soc 2003, 51:1085-1091.
29. Kripke DF, Youngstedt SD, Elliott JA, Tuunainen A, Rex KM, Hauger
RL, Marler MR: Circadian phase in adults of contrasting ages.
Chronobiol Intl 2005, 22:695-709.
30. Kripke DF, Clopton P, Marler MR, Youngstedt SD, Elliott JA: PRC
bisection tests.  Chronobiol Int 2003, 20:1117-1123.
31. Benloucif S, Green K, L'Hermite-Baleriaux M, Weintraub S, Wolfe LF,
Zee PC: Responsiveness of the aging circadian clock to light.
Neurobiol Aging 2005, 27:1870-1879.
32. Duffy JF, Zeitzer JM, Czeisler CA: Decreased sensitivity to phase-
delaying effects of moderate intensity light in older subjects.
Neurobiol Aging 2007, 28:799-807.
33. Kripke DF, Jean-Louis G, Elliott JA, Klauber MR, Rex KM, Tuunainen
A, Langer RD: Ethnicity, sleep, mood, and illumination in post-
menopausal women.  BMC Psychiatry 2004, 4:8.
34. Jean-Louis G, Kripke D, Cohen C, Zizi F, Wolintz A: Associations
of ambient illumination with mood:  Contribution of oph-
thalmic dysfunctions.  Physiol Behav 2005, 84:479-487.
35. Hannibal J, Hindersson P, Ostergaard J, Georg B, Heegaard S, Larsen
PJ, Fahrenkrug J: Melanopsin is expressed in PACAP-containing
retinal ganglion cells of the human retinohypothalamic tract.
Invest Ophthalmol Vis Sci 2004, 45:4202-4209.
36. Cagnacci A, Elliott JA, Yen S: Melatonin: a major regulator of the
circadian rhythm of core temperature in humans.  J Clin Endo-
crinol Metab 1992, 75:447-452.
37. Duffy JF, Zeitzer JM, Rimmer DW, Klerman EB, Dijk DJ, Czeisler CA:
Peak of circadian melatonin rhythm occurs later within the
sleep of older subjects.  Am J Physiol Endocrinol Metab 2002,
282:E297-E303.
38. Tozawa T, Mishima K, Satoh K, Echizenya M, Shimizu T, Hishikawa Y:
Stability of sleep timing against the melatonin secretion
rhythm with advancing age:  clinical implications.  J Clin Endo-
crinol Metab 2003, 88:4689-4695.
39. Zhou JN, Liu RY, van Heerikhuize J, Hofman MA, Swaab DF: Altera-
tions in the circadian rhythm of salivary melatonin begin dur-
ing middle-age.  J Pineal Res 2003, 34:11-16.
40. Elliott JA, Tamarkin L: Complex circadian regulation of pineal
melatonin and wheel-running in Syrian hamsters.  J Comp Phys-
iol A 1994, 174:469-484.
41. Tuunainen A, Kripke DF, Elliott JA, Assmus JD, Rex KM, Klauber MR,
Langer RD: Depression and endogenous melatonin in post-
menopausal women.  J Affect Disord 2002, 69(1-3):149-158.
42. Pittendrigh CS, Elliott JA, Takamura T: The circadian component
in photoperiodic induction.  CIBA Foundation Symposium 1984,
104:26-47.
43. Burgess HJ, Eastman CI: Short nights attenuate light-induced
circadian phase advances in humans.  J Clin Endocrinol Metab
2005, 90:4437-4440.
44. Burgess HJ, Eastman CI: Short nights reduce light-induced circa-
dian phase delays in humans.  Sleep 2006, 29:25-30.
45. Jewett ME, Rimmer DW, Duffy JF, Klerman EB, Kronauer RE, Czeisler
CA: Human circadian pacemaker is sensitive to light
throughout subjective day without evidence of transients.
Am J Physiol 1997, 273:R1800-R1809.
46. Honma K, Hashimoto S, Nakao M, Honma S: Period and phase
adjustments of human circadian rhythms in the real world.  J
Biol Rhythms 2003, 18:261-270.
47. Williams TP, Thistle AB: Photostasis and Related Phenomena New York,
Plenum; 1998:1-225. Page 13 of 13
(page number not for citation purposes)
